Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2

GENEVA–(BUSINESS WIRE)–Alcon Acquires Neurotech and ENCELTO, the Only FDA Approved Treatment for MacTel Type 2